A Study of XY0206 in Subjects With Advanced or Metastatic Solid Tumours

NCT03658070 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumours

Interventions

DRUG: XY0206

Sponsor

Shijiazhuang Yiling Pharmaceutical Co. Ltd

Collaborators

[object Object]